-
101
-
102
COVID‐associated non‐vasculitic thrombotic retiform purpura of the face and extremities: A case report
Published 2022-12-01Get full text
Article -
103
-
104
A FRET sensor for the real-time detection of long chain acyl-CoAs and synthetic ABHD5 ligands
Published 2023-02-01Get full text
Article -
105
-
106
Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies
Published 2023-09-01Get full text
Article -
107
Titanium Alloy Implants with Lattice Structures for Mandibular Reconstruction
Published 2023-12-01Get full text
Article -
108
Is Remote Ischemic Conditioning of Benefit to Patients Undergoing Kidney Transplantation?
Published 2019-01-01Get full text
Article -
109
-
110
-
111
-
112
-
113
Mechanical Circulatory Support for Complex High-risk Percutaneous Coronary Intervention
Published 2023-04-01Get full text
Article -
114
-
115
-
116
-
117
-
118
Clinical trials and progress with paclitaxel in ovarian cancer
Published 2010-11-01“…Sanjeev Kumar1, Haider Mahdi2, Christopher Bryant1, Jay P Shah1, Gunjal Garg3, Adnan Munkarah41Department of Obstetrics and Gynecology, Wayne State University School of Medicine and Karmanos Cancer Institute Detroit, Michigan; 2Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington; 3Department of Obstetrics and Gynecology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; 4Department of Obstetrics and Gynecology, Henry Ford Hospital, Detroit, Michigan, USAAbstract: Paclitaxel is a front-line agent for ovarian cancer chemotherapy, along with the platinum agents. …”
Get full text
Article -
119
-
120